Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P11
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -26.01% |
| 2024 | 48.40% |
| 2023 | 33.05% |
| 2022 | -64.93% |
| 2021 | 25.02% |
| 2020 | 30.52% |
| 2019 | 225.51% |
| 2018 | 0.00% |
| 2013 | 0.00% |
| 2012 | 0.00% |